McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone415-983-8300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$208.36 billion
Profitability
Miscellaneous
Employees78,000
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson announced a quarterly dividend on Thursday, October 25th. Shareholders of record on Monday, December 3rd will be given a dividend of $0.39 per share on Wednesday, January 2nd. This represents a $1.56 annualized dividend and a yield of 1.25%. The ex-dividend date is Friday, November 30th. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) announced its quarterly earnings data on Thursday, October, 25th. The company reported $3.60 EPS for the quarter, topping analysts' consensus estimates of $3.28 by $0.32. The firm earned $53.08 billion during the quarter, compared to analyst estimates of $53.56 billion. McKesson had a net margin of 0.06% and a return on equity of 26.55%. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY 2019 earnings guidance on Thursday, October, 25th. The company provided EPS guidance of $13.20-13.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.29.
What price target have analysts set for MCK?
14 brokers have issued 1 year target prices for McKesson's shares. Their forecasts range from $2.86 to $180.00. On average, they expect McKesson's share price to reach $136.7383 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
News coverage about MCK stock has been trending very positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. McKesson earned a media sentiment score of 3.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Are investors shorting McKesson?
McKesson saw a increase in short interest during the month of December. As of December 14th, there was short interest totalling 5,157,397 shares, an increase of 60.1% from the November 30th total of 3,220,745 shares. Based on an average daily volume of 1,870,029 shares, the short-interest ratio is currently 2.8 days. Currently, 2.6% of the company's shares are short sold. View McKesson's Current Options Chain.
Who are some of McKesson's key competitors?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 59)
- Britt J. Vitalone, CFO & Exec. VP (Age 49)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 56)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 57)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 53)
Who are McKesson's major shareholders?
McKesson's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Clarkston Capital Partners LLC (0.07%), Nisa Investment Advisors LLC (0.05%), Bell Asset Management Ltd (0.03%), DNB Asset Management AS (0.03%), Gulf International Bank UK Ltd (0.02%) and Kempner Capital Management Inc. (0.02%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and N Anthony Coles. View Institutional Ownership Trends for McKesson.
Which institutional investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including Horan Capital Management, DNB Asset Management AS, Consolidated Investment Group LLC, Gulf International Bank UK Ltd, Trust Department MB Financial Bank N A, Carroll Financial Associates Inc., Moon Capital Management LLC and Granite Investment Advisors LLC. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, Lori A Schechter and N Anthony Coles. View Insider Buying and Selling for McKesson.
Which institutional investors are buying McKesson stock?
MCK stock was acquired by a variety of institutional investors in the last quarter, including Oakbrook Investments LLC, Kempner Capital Management Inc., Highland Capital Management LLC, Bell Asset Management Ltd, Virtu Financial LLC, First Hawaiian Bank, Clarkston Capital Partners LLC and Fulton Bank N.A.. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $125.23.
How big of a company is McKesson?
McKesson has a market capitalization of $24.75 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is ONE POST ST, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
